Chronic Pain, Therapeutic Exercise
Conditions
Brief summary
Fibromyalgia syndrome is characterized by chronic generalized musculoskeletal pain associated with fatigue, sleep disturbances and some biochemical markers. The European League Againts Rheumatism (EULAR) described an algorithm how to treat step by step these patients. The objective of this trial is to evaluate if therapeutic exercise is effective on fatigue, pain threshold, quality of life, quality of sleep, pain coping and biochemical and genetic markers. For this purpose, the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of fibromyalgia according to the American College of Rheumatology (ACR). Patients included one group receiving exercise therapy consisting of 3 treatment sessions a week over 10 weeks. The variables are measured at the beginning and end of treatment.
Interventions
OTHERTherapeutic Exercise
Exercise therapy based primarily in aerobic exercise according clinical guidelines last recommendations.To perform different whole body aerobic exercises with a mild to moderate intensity according to Borg scale and maximum heart rate.
Sponsors
Universidad de Zaragoza
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosed medically with Fibromyalgia * Diagnosed according to the American College of Rheumatology criteria * Agreement to attend to treatment sessions
Exclusion criteria
* Any kind of contraindications for physical activity * Other kind of diseases that could limit the intervention * Previous surgery last year * Medication modifications in the last 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity | Baseline | VAS |
| Quality of Sleep | Baseline | The investigators measure the quality of sleep with Pittsburg Sleeping Questionnaire Index (PSQI) at baseline |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Analysis of tryptophan metabolites | Baseline | The investigators measure the tryptophan metabolites with blood test analysis at baseline |
| Pressure pain threshold | Baseline | The investigators measure the pressure pain threshold of the 18 points described initially by the American College of rheumatology with a digital algometer at baseline |
| Central sensitization | Baseline | The investigators measure the central sensitization with Chronic Pain Self-Efficacy Scale (CPSS) at baseline |
Countries
Spain
Outcome results
None listed